Roivant Sciences Ltd
NASDAQ:ROIV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
BM |
|
Mare Engineering Group SpA
MIL:MARE
|
IT |
|
A
|
ACS Actividades de Construccion y Servicios SA
VSE:ACS
|
ES |
|
Facephi Biometria SA
MAD:FACE
|
ES |
|
Amundi SA
PAR:AMUN
|
FR |
Intrinsic Value
Is ROIV undervalued or overvalued?
See the intrinsic value estimate for Roivant Sciences Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
ROIV looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with ROIV’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Roivant Sciences Does
Roivant Sciences is a biopharmaceutical company that builds and backs drug-development businesses, often by taking promising medicines or research programs and placing them in focused subsidiaries. It does not mainly sell everyday products; instead, it works on developing treatments and moving them through clinical testing and, if successful, toward approval and commercialization.
- Headquarters
- Bermuda BM
- Employees
- 665
- IPO date
- Dec 3, 2020
Earnings Waterfall
Roivant Sciences Ltd
The intrinsic value for Roivant Sciences Ltd (ROIV) under the Base Case is hidden USD.
Compared with the current market price of 36.54 USD, the stock appears hidden.